KalVista Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending April 30, 2024 was -$48.5M, a 52.7% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending April 30, 2024 was -$140M, a 26.7% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$140M, a 26.7% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$111M, a 14.8% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$96.6M, a 66.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$140M -$48.5M -$16.7M -52.7% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-11
Q4 2023 -$124M -$33.2M -$6.21M -23% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$118M -$29.7M -$3.86M -14.9% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-07
Q2 2023 -$114M -$29.1M -$2.78M -10.6% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q1 2023 -$111M -$31.7M -$4.92M -18.3% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-11
Q4 2022 -$106M -$26.9M -$262K -0.98% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 -$106M -$25.9M -$2.28M -9.66% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-07
Q2 2022 -$103M -$26.3M -$6.8M -34.8% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q1 2022 -$96.6M -$26.8M -$8.77M -48.6% Feb 1, 2022 Apr 30, 2022 10-K 2024-07-11
Q4 2021 -$87.8M -$26.7M -$14M -111% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 -$73.8M -$23.6M -$10.8M -84.7% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-08
Q2 2021 -$63M -$19.5M -$5.07M -35.1% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q1 2021 -$57.9M -$18M -$9.09M -101% Feb 1, 2021 Apr 30, 2021 10-K 2023-07-10
Q4 2020 -$48.8M -$12.7M +$67K +0.53% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-10
Q3 2020 -$48.9M -$12.8M -$3.49M -37.6% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-09
Q2 2020 -$45.4M -$14.4M -$4.88M -51% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q1 2020 -$40.5M -$8.96M +$2.3M +20.4% Feb 1, 2020 Apr 30, 2020 10-K 2022-07-07
Q4 2019 -$42.8M -$12.7M -$6.06M -91.1% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 -$36.8M -$9.29M -$4.4M -89.8% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-10
Q2 2019 -$32.4M -$9.56M -$2.56M -36.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 -$29.8M -$11.3M -$8.29M -279% Feb 1, 2019 Apr 30, 2019 10-K 2021-07-13
Q4 2018 -$21.5M -$6.66M -$2.31M -53.2% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-10
Q3 2018 -$19.2M -$4.89M +$1.04M +17.6% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-03
Q2 2018 -$20.3M -$7.01M -$1.56M -28.5% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 -$18.7M -$2.97M +$1.88M +38.8% Feb 1, 2018 Apr 30, 2018 10-K 2020-07-01
Q4 2017 -$20.6M -$4.35M +$3.77M +46.5% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 -$24.4M -$5.94M -$3.53M -147% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 -$20.8M -$5.45M +$1.51M +21.7% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$22.3M -$4.85M +$1.68M +25.7% Feb 1, 2017 Apr 30, 2017 10-K 2019-07-16
Q4 2016 -$24M -$8.12M -$4.3M -113% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-16
Q3 2016 -$19.7M -$2.41M +$2.49M +50.9% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$22.2M -$6.96M -$1.3M -22.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 -$20.9M -$6.53M -$1.63M -33.2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$19.3M -$3.82M +$2K +0.05% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-16
Q3 2015 -$19.3M -$4.9M -$1.33M -37.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$18M -$5.67M -$3.23M -133% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$14.7M -$4.9M -$3.05M -164% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$11.7M -$3.82M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$3.57M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.44M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.86M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.